AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75N93021C00032ADAPTIVE PHAGE THERAPEUTICS, LLC
Overview
Award facts
- Net obligations
- $296.79K
- $296,787of $296.79K potential value
- Outlays (paid to date)
- $296.79K
- $296.79K paid of $296.79K obligated$296,787
- Period of performance
- Aug 16, 2021 to Aug 15, 2022
- Ended
- Modifications
- 3
- Latest action Nov 24, 2021
- Contract type
- Definitive contract
- PIID 75N93021C00032
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
TO AWARD SBIR PHASE I TO ADAPTIVE PHAGE THERAPEUTICS, INC.
Dates and value
- Award date
- Signed on Aug 16, 2021
- Potential end of performance
- Aug 14, 2022
- Current value
- $296,787Base and exercised options
- Potential value (if all options are exercised)
- $296,787
Obligations by fiscal year of action
- FY2021: $296,787
Total across 1 fiscal year: $296,787
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 24, 2021. View on USAspending · Recipient on SAM.gov
Recipient
LocationBETHESDA, MD
UEIPWCMZJMBSNK6
CAGE code7W7L6
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyADAPTIVE PHAGE THERAPEUTICS, LLC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Bethesda, Montgomery County, Maryland 20817-2353
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Not available for competitionB
- Reason not competed
- Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 6
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Development of a rapid and scalable method for bacteriophage manufacture and purification
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Services pursuant to FAR 12.102(G)C
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 16, 2021Base obligation at award: $296,787
- Latest action
- Nov 24, 2021 — Funding onlyModification P00003; funding only: changes obligations, not scope
- Latest funding action
- Nov 24, 2021 — Funding onlyModification P00003; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Funding only2
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2021/2021-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression